학술논문

463P Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer with an extended follow-up
Document Type
Abstract
Source
In Annals of Oncology September 2022 33 Supplement 7:S751-S752
Subject
Language
ISSN
0923-7534